Erzofri extended-release (paliperidone palmitate)

**Product type:** Human Prescription Drug

**Active ingredient:** PALIPERIDONE PALMITATE

**Strength:** 156 mg/mL

**Dosage form:** Injection

**Route:** Intramuscular

**Labeler:** Shandong Luye Pharmaceutical Co., Ltd.

**Marketing category:** NDA (NDA216352)

**Pharmacologic class:** Atypical Antipsychotic [EPC]